论文部分内容阅读
糖尿病是21世纪的流行病,是继心脑血管病和癌症之后的第三大疾病。我国目前的糖尿病患者已达到4000万名左右,并且呈逐年增多趋势。其中,大约90％为2型糖尿病。糖尿病严重影响人们寿命和生命质量,并给个人、家庭和政府带来沉重的经济负担。据最新公布的中国第一个糖尿病领域的的一项药物经济学研究——《中国城市治疗2型糖尿病及其并发症的成本》结果显示,糖尿病人中46.7％无并发症,53.3％有并发症。研究推算,城市治疗2型糖尿病及其并发症的直接
Diabetes is a 21st century epidemic that is the third most common disease after cardiovascular disease and cancer. At present, the number of diabetics in China has reached about 40 million, and the trend of increasing year by year. About 90% of them are type 2 diabetes. Diabetes seriously affects people’s life expectancy and quality of life, and carries a heavy financial burden on individuals, families and governments. According to a newly released study of pharmacoeconomics in China’s first diabetes field, “The Costs of Treating Type 2 Diabetes and Its Complications in Chinese Cities” showed that 46.7% of the patients without diabetes had complications and 53.3% had complications disease. Research projections, urban treatment of type 2 diabetes and its complications directly